These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 10508285)

  • 21. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parameters of dynamic contrast-enhanced MRI as imaging markers for angiogenesis and proliferation in human breast cancer.
    Li L; Wang K; Sun X; Wang K; Sun Y; Zhang G; Shen B
    Med Sci Monit; 2015 Feb; 21():376-82. PubMed ID: 25640082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing tumor angiogenesis using macromolecular MR imaging contrast media.
    Brasch R; Pham C; Shames D; Roberts T; van Dijke K; van Bruggen N; Mann J; Ostrowitzki S; Melnyk O
    J Magn Reson Imaging; 1997; 7(1):68-74. PubMed ID: 9039595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors.
    Carriero A; Ambrossini R; Mattei PA; Angelucci D; Bonomo L
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):83-7. PubMed ID: 12585660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D dynamic contrast-enhanced MRI of rectal carcinoma at 3T: correlation with microvascular density and vascular endothelial growth factor markers of tumor angiogenesis.
    Zhang XM; Yu D; Zhang HL; Dai Y; Bi D; Liu Z; Prince MR; Li C
    J Magn Reson Imaging; 2008 Jun; 27(6):1309-16. PubMed ID: 18504761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in vascular endothelial growth factor receptor expression and correlation with the degree of enhancement in medulloblastoma.
    Hervey-Jumper SL; Garton HJ; Lau D; Altshuler D; Quint DJ; Robertson PL; Muraszko KM; Maher CO
    J Neurosurg Pediatr; 2014 Aug; 14(2):121-8. PubMed ID: 24905841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Magnetic resonance imaging of breast cancer: correlation between contrast enhancement and tumor angiogenesis].
    Furuta A; Ishibashi T; Takahashi S; Yamada S; Ohuchi N; Amano G; Goto K; Watanabe M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):682-8. PubMed ID: 10565172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma.
    Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N
    Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
    Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
    Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
    Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
    Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma.
    Guidi AJ; Abu-Jawdeh G; Tognazzi K; Dvorak HF; Brown LF
    Cancer; 1996 Aug; 78(3):454-60. PubMed ID: 8697391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
    Cheng HL; Wallis C; Shou Z; Farhat WA
    J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions.
    Stomper PC; Winston JS; Herman S; Klippenstein DL; Arredondo MA; Blumenson LE
    Breast Cancer Res Treat; 1997 Aug; 45(1):39-46. PubMed ID: 9285115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors.
    Matsubayashi R; Matsuo Y; Edakuni G; Satoh T; Tokunaga O; Kudo S
    Radiology; 2000 Dec; 217(3):841-8. PubMed ID: 11110952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic contrast-enhanced magnetic resonance imaging in oncology.
    Knopp MV; Giesel FL; Marcos H; von Tengg-Kobligk H; Choyke P
    Top Magn Reson Imaging; 2001 Aug; 12(4):301-8. PubMed ID: 11687716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
    Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
    Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
    Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed model of gadolinium enhanced MRI of breast disease.
    Kenney PJ; Sobol WT; Smith JK; Morgan DE
    Eur J Radiol; 1997 Feb; 24(2):109-19. PubMed ID: 9097052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
    Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
    Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.